Alstoe Animal Health is launching Nelio, a four-way breakable flavoured tablet version of the ACE inhibitor benazepril hydrochloride at BSAVA Congress.
The Nelio range for the treatment of congestive heart failure in dogs and chronic renal insufficiency in cats is presented as a flavoured clover-shaped scored tablet, which is easily divisible into halves or quarters. Nelio is presented in 5mg and 20mg tablets for dogs and 5mg for cats. The company says the new product will allow for more accurate dosing by bodyweight.
In addition, Alstoe is introducing a 120mg sized Dolagis chewable flavoured tablet, which contains the largest amount of carprofen in a single tablet on the veterinary market. As with the 50mg version, the 120mg tablet can be broken into half and quarter portion doses. Alstoe says the combination of these two sizes now affords even greater versatility for veterinary surgeons who need to prescribe for different weights of patient.
CEVA Animal Health has updated its practice support materials to include an all-encompassing D.A.P. client leaflet, a website and a new vet detailer.
The new materials, which also include a D.A.P. and Feliway reference guide containing details of 31 published trials into the practical applications of pheromones, focus on using D.A.P. to prevent stress at key stages of a dog's life. Particular attention is paid to the benefits of fitting a D.A.P. Collar during early puppy consults in order to help prepare dogs for the modern world and helping to prevent anxiety-related problems such as separation anxiety and noise phobia, developing in later life. In addition, the vet brochure will draw practitioners' attention to the times in a dog's life when owners are particularly concerned about their dog becoming stressed including events like trips to boarding kennels.
Lucy Brett, product manager at CEVA Animal Health, said: "Over the last three years eight different trials have been published looking at the use of pheromones to reduce canine stress. The latest data backs up what we have believed for some time - that the management of stress during socialisation is vital if dogs are to grow into emotionally balanced and confident adult dogs. We now have a much better idea of the impact of allowing puppies to get stressed or overwhelmed during socialisation and the difference providing pheromone support in the form of a D.A.P. Collar can make."
For further details, or for information on CEVA's range of educational resources for veterinary professionals interested in feline and canine behaviour, please contact your CEVA Animal Health representative or call 01494 781510.
The Royal College of Veterinary Surgeons Trust's Adopt-A-Book campaign has raised almost £17k in sponsorship to pay for the restoration of books in the historical collection.
The latest book to be restored under the scheme is a nineteenth century edition of Every man his own farrier, by F. Clater, which has been restored thanks to veterinary surgeon Fiona Dalzell.
Fiona said: "I have always loved books, and especially old books, but I got inspired by the Adopt-a-Book scheme when I came to the RCVS for a meeting of the Veterinary History Society".
These editions, she says, are "works of art in their own right," and it has given her a "huge amount of pleasure to know that you can do so much just from a small donation."
RCVS Trust Director Cherry Bushell explained the idea behind a campaign: "When you think of 'adoption', you may more readily recall the rescue animals treated in veterinary practices than old books. However, these old books also need your help - and are an important part of the veterinary heritage that the Trust seeks to preserve."
Restoring a book can cost between £25 and £250, and adopted books carry a book-plate naming their benefactor. They can also be dedicated 'in memoriam'.
Since its inception six years ago, the Adopt-a-Book campaign has raised £16, 851, and funded the restoration of 139 volumes:
Those interested in supporting this work by adopting a book can view available titles at www.rcvs.org.uk/adoptabook or contact Clare Boulton, RCVS Trust Librarian (c.boulton@rcvstrust.org.uk or 020 7202 0752).
Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.
The campaign will see a new TV 'public information' style advertisement targeting dog owners. It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.
The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.
Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.
Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative. For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
Thought i would let you all know, that we have now reach the milestone of 100 SAMSOC members registered on the site.
The commitee is now starting to look for new ideas to develop within the site that will benefit members. Current features include - the forum, a wiki for listing projects that are recruiting cases and a media section for interesting radiographs/case material.
If you have any good ideas please contact us and we will see what we can do
All the best and see you tommorow
Ian
PS- There are still some members have yet to register on the site. So if you know one of them give them a nudge.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
A Royal College of Veterinary Surgeons audit panel is to visit UK veterinary schools to assess how Extra-Mural Studies (EMS) is being carried out, identify good practice and make recommendations for improvement. The exercise is part of a package of measures which aims to improve the way that EMS helps veterinary undergraduates to gain skills and knowledge in a practice environment.
RCVS Council agreed to the implementation of proposals made by a Working Party set up to review the whole EMS process in November 2009. While the EMS system was largely agreed to be valuable and working well, some areas were identified for improvement. Many of the recommendations centred on a better understanding amongst all parties involved - students, practices and vet schools - of the aims and objectives of EMS for the student, and improved communication about expectations and outcomes.
As a first step, the Education Policy and Specialisation Committee has put in place an audit of EMS at the veterinary schools. It has commissioned Dr Barry Johnson, who led the original Working Party, together with practitioners David Black, David Wadsworth and Dr Chris Chesney, to follow through individual cases, talking to the students, practitioners and clinical tutors and EMS co-ordinators at the vet schools, to build a picture of how administration, communication and follow-up is managed.
Barry said: "The objective of the audit is to identify areas of good practice that can be shared, and identify where improvements could be made - it will also promote dialogue between practices and the schools. The exercise will be repeated over the next couple of years to track changes."
The first audit took place at the Royal Veterinary College in February, as part of the full RCVS visitation of the undergraduate degree programme. The EMS audit panel will report its initial findings in June.
The full report and recommendations from the EMS Working Party can be viewed at www.rcvs.org.uk/EMS.
AT Veterinary Systems has launched the IRIS Imaging Solution, a 'digital hub' for veterinary practices which the company says goes beyond many traditional PACS (Picture Archiving Communications Systems), offering a multi-user and multi-screen imaging solution.
With IRIS Imaging Solution practice staff can archive, access, view, process, manipulate, review and communicate DICOM files and other digital media, as well as entire DICOM studies (constituting multiple files) from any terminal on the network. These DICOM files can be stored together with clinical and patient records as well as text notes, lab reports, forms, photos and images.
AT Veterinary Systems says IRIS is ideal for practices that want a cost-effective, quick and easy to use imaging solution that is especially configured for swift data transfer throughout a network. Added benefits also include a large data storage capacity, off site data storage facility, remote access capability and automated data back up and network synchronisation.
Jacqui Garrett, Business Development Manager at AT Veterinary Systems said: "We work hard at AT Veterinary Systems to offer veterinary practices cutting edge software that meets all of their needs. With IRIS Imaging Solution we have employed the latest technology to provide a professional, dynamic and easy to use imaging and information management system."
For more information about IRIS Imaging Solution please visit http://www.irisimaging.co.uk/
US company Midmark is running a UK prize draw to win a Cardell 9401 blood pressure monitor worth nearly £2000.
To enter the draw, click here.
Free plasma metanephrines – a novel diagnostic approach for the diagnosis of pheochromocytoma in dogs
The Royal Veterinary College is investigating whether an increased plasma metanephrine concentration can be used to identify pheochromocytomas in dogs. We hope this will provide a useful indicator for pheochromocytomas, which are otherwise challenging to diagnose and our preliminary data suggests that plasma metanephrine concentrations increase in affected dogs.
EDTA plasma samples are being submitted for metanephrine measurement by High Pressure Liquid Chromatography (HPLC) and we also plan to validate a radioimmunoassay for metanephrine measurement.
We would welcome EDTA plasma samples from dogs undergoing investigation of adrenal masses, especially if pheochromocytoma is strongly suspected. The full cost of this test will be covered by the project grant and HPLC results are usually available within 7 days.
For further information or to discuss submitting a sample for analysis, please contact:
Ruth Gostelow BVetMed (Hons) MRCVS
Senior Clinical Training Scholar in Small Animal Internal Medicine
Email: rgostelow@rvc.ac.uk
Or call the RVC Clinical Investigations Centre on 01707 666605
Fellow investigator: Harriet Syme BSc BVetMed PhD MRCVS D-ACVIM D-ECVIM
Other projects listed in the SAMSOC Wiki
VetSurgeon member Howard Wilder, founder and managing director of British veterinary pharmaceutical company Genitrix, has been named Director of the Year at the 2010 Institute of Directors' London and South East Director of the Year Awards.
Genitrix provides treatments and therapies for pets and horses, and has just launched Libromide, the UK's first licensed formulation of potassium bromide, used in the treatment of canine epilepsy. Howard won the award in the category for businesses with a turnover of up to £4.99 million.
Howard said: "I founded Genitrix in 1998 and it's undoubtedly my greatest achievement. From scratch, and in just 12 years, we've become one of the top 20 companies in the veterinary pharmaceutical sector and compete strongly with multi-million dollar global corporations.
"I'm absolutely thrilled to have won. It's recognition both of the success of Genitrix and for me personally. I've worked very hard to make Genitrix the best run business in the sector and this confirms that I'm heading in the right direction."
Dogs Trust has come out firmly against RSPCA-supported proposals to re-introduce the dog licence.
The dog welfare charity says it does not believe re-introducing the dog licence would provide a welfare benefit for dogs. It has also expressed surprise at the RSPCA position, which is that: "a licence would be hugely beneficial in addressing many animal welfare concerns stemming from overbreeding of dogs to a lack of traceable ownership." Dogs Trust has said this view is extremely naïve, that responsible owners might struggle to pay what is likely to be a punitive annual licence, and that a licence is simply a tax on dog ownership.
Meanwhile, the RSPCA has announced the results of a survey in which 2 out of 3 pet owners said they would be in favour of a licence scheme. 76% said that a dog licence should be enforced in England to help curb problems such as 'puppy farms', stray dogs, stolen dogs and animal abandonments.
The RSPCA also says that research carried out on its behalf by Reading University clearly shows that an affordable and well-enforced dog licensing scheme could provide funding for a range of issues, most of which are currently funded poorly by central and local government. Professor Emeritus Martin Upton from Reading University's school of agriculture, policy and development, said: "Our study into the potential costs and benefits of dog licencing and registration found that such a scheme could greatly contribute to responsible dog ownership and animal welfare."
Dogs Trust says the dog licence has been shown to be an ineffective measure in the UK. In Northern Ireland, where the dog licence is still a requirement, only an estimated one-third of all dog owners currently have their dogs licensed. Northern Ireland still has the highest number of stray dogs per head of population of any region in the UK and the number of dogs put to sleep in the region represents a staggering 34% of the total UK figure.
The charity recommends compulsory microchipping as the most effective means of registration as well as identification of a dog. Unlike the dog licence, which involves an annual fee, microchipping involves just a small one-off fee (Dogs Trust offers microchipping at its centres for £10). The benefit to responsible owners and their dogs is therefore relatively cheap and effective. Microchipping a dog should infer legal ownership and reinforces the responsibilities of the owner under the Animal Welfare Act. The introduction of compulsory microchipping would allow stray dogs to be quickly returned to their owners, make easier the identification of owners who persistently allow their dogs to stray or cause nuisance, and make all puppies traceable to their breeder, helping to reduce the widespread problem of battery farming of dogs.
Each year the WSAVA Congress is held in a different location around the world and attracts over 70,000 veterinary professionals who relish the opportunity to hear from top international speakers on all aspects of practicing small animal veterinary medicine.
The WSAVA is an international network of associations dedicated to the continuing development of companion animal care around the world. It brings veterinary practitioners and academia together to help enhance the knowledge of specific topics, such as hereditary disease and nomenclature of pathological processes.
To celebrate the Association's 50th anniversary Professor Michael J Day, chairman of the WSAVA Scientific Advisory Committee, has proposed that this year be the year of 'One Medicine'. The theme is intended to recognise the importance of the link between the medical and veterinary professions. It will encompass the human population, domestic animals and wildlife, and the impact that current environmental changes are having on these groups. Lectures and seminars during this year's congress will reflect the 'One Medicine' topic, looking for an exchange of ideas and to build the foundations for future developments of mutual interest. For further information please visit http://www.wsava2010.org/.
Veterinary staff can enter the WSAVA prize draw by visiting Petplan at stand 311 during the BSAVA Congress or via the dedicated Petplan veterinary staff website, petplanvet.co.uk.
A new paper by D J Bartram and D S Baldwin, published in this week's Veterinary Record, has found that veterinary surgeons are four times as likely as the general public, and around twice as likely as other healthcare professionals, to die by suicide as opposed to other causes.
Professor Bill Reilly, President of the British Veterinary Association, said: "David Bartram's research in this difficult area is to be applauded. The more we can understand about the reasons behind the high suicide rate amongst veterinary surgeons, the more the BVA and other bodies can do to support vets in crisis.
"As part of the Vetlife Steering Group, the BVA supports fantastic initiatives such as the 24-hour Vet Helpline for vets, vet nurses and veterinary students, and the Veterinary Benevolent Fund.
"The BVA's Member Services Group (MSG) also spends a lot of time looking at practical initiatives to improve individual vets' day-to day lives. The recent introduction of the mediation and representation services to help resolve issues between veterinary employees and veterinary employers is a good example of the positive ways in which the BVA can support its members in difficult situations.
"The MSG also recently produced a helpline sticker for all veterinary practices to display on the medicines cabinet and other prominent places to act as a constant reminder that help is available.
"Ours is a small profession and many vets will know a friend or colleague who has taken their own life. It is essential that this issue is kept in the open so that those who are struggling know where to turn for help."
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
See attachment for info on discounted rates for BSAVA manuals at pre congress meeting
Best wishes
Yvonne
Willows Referral Service
Locum Internal Medicine Clinician required
During 2010 Willows Referral Service has opportunities for part-time Internal Medicine locum cover. The successful applicant(s) should either hold an RCVS, European or American Diploma (or equivalent) or have undertaken Residency training and be ready to take their final Diploma examinations. Candidates must share our aim of providing the best possible levels of care for clients, their pets and for referring veterinary surgeons.
We have an excellent team of support staff who give our clinicians the opportunity to concentrate on their clinical caseload and to work in a pleasant, supportive and good humoured atmosphere. Facilities include a superbly equipped intensive care unit, kennelling for over 100 in-patients, all-new GE imaging equipment, including 1.5T MRI, top-end 16 slice CT with in-room CT fluoroscopy, two general digital X-ray rooms, mobile image intensifier, high-end ultrasound and Olympus video endoscopy. Our medicine clinicians, Jane Eastwood DSAM and Kirsty Roe DipACVIM, work alongside specialists in the disciplines of soft tissue surgery, neurology, ophthalmology, orthopaedics, imaging and anaesthesia, and our philosophy is very much one of friendly co-operation between clinicians in every specialism.
For further information about Willows internal medicine service please visit http://www.willows.uk.net/en-GB/specialist-services/specialisms/internal-medicine
If you are interested and would like an informal chat about the position, please contact Jane Eastwood on 0121 712 7070
Willows Veterinary Centre & Referral Service, Solihull, West Midlands www.willows.uk.net
Veterinary surgeons can consider a wider range of options when it comes to neutering cats and dogs. This was the message from veterinary reproduction specialist Angelika von Heimendahl MSc BVM(Berlin) MRCVS DipECAR, at a recent seminar on reproductive health organised by Virbac.
Mrs von Heimendahl, who runs the Cambridge based referral centre, Veterinary Reproduction Service, said: "Globally the approach to neutering varies hugely. Although neutering is considered as part of responsible pet ownership in the UK and performed routinely in every practice in the country, at the other end of the scale, in Germany and Scandinavia for example, this is considered mutilation and is prohibited by law.
"Despite the very low neutering rates - Norway 7% compared to UK around 80% - in these countries they do not have a problem with stray dogs, indicating that there are other factors such as education and attitudes to dog ownership that play a major role."
She added: "In other continental countries, bitch spaying is usually by ovariectomy rather than ovariohysterectomy.
"Some practices are now successfully offering clients a range of options, including medical castration, especially with new reproduction drugs recently introduced onto the market. The non-surgical contraceptive slow-release implant, deslorelin (Suprelorin), a GnRH superagonist lasts for six months, making medical castration a more practical solution for many owners."
Mrs Von Heimendahl also suggested that deslorelin, although off-licence, can be used in bitches as an alternative to spaying: "Whilst neutering can have advantages in terms of reduced incidence of certain cancers, there are also advantages of retaining both male and female dogs intact. Some cancers are less likely to occur in intact animals, for example there is a reduced risk of transitional cell carcinomas, haemangiosarcomas and osteosarcomas. Obesity and its associated problems are also less of an issue, which is a particular benefit for owners where the necessary reduced calorie intake post neutering is difficult to achieve."
Chris Taylor MRCVS, technical director of seminar organiser, Virbac, added that medical castration can offer dog owners the opportunity to 'test run' neutering of their animal, and pointed out that this is particularly useful for behavioural issues in young male dogs: "Twice yearly implants offer a practical alternative for clients, whether as a short or longer-term solution. As a solution focussed business, we are constantly striving to put forward a choice of options which can only have benefits for client and practice alike."
Novartis Animal Health has launched Zolvix, billed as the first truly novel anthelmintic class for livestock to be launched in more than 25 years, together with a new drenching system designed to make drenching faster, easier and more accurate.
Zolvix contains a new active ingredient, monepantel, which kills all key sheep gastro-intestinal nematodes (roundworms), including those resistant to the existing treatments.
According to the company, the development of this new drench follows the persistent challenge from worms that have developed resistance to the three other classes of drench - white (benzimidazole or 1-BZ), yellow (levamisole or 2-LV) and clear (macrocyclic lactone or 3-ML) and combinations of these. Zolvix has a unique mode of action and so forms a fourth generation of anthelmintic, which will be known as the 4- AD, or orange drench class
Novartis Animal Health has prioritised the UK and Ireland as key launch countries for Zolvix to provide their sheep farmers with an answer to the pressing challenge of increasing anthelmintic resistance.
Lesley Stubbings, an Independent sheep consultant and Sustainable Control of Parasites in Sheep (SCOPS) panel member, said: "Resistance has become an ever increasing threat since the last new anthelmintic group was introduced to the UK market more than 25 years ago. Zolvix offers farmers a valuable opportunity to maintain good worm control and prolong the effective life of the existing products. Following the SCOPS guidelines to carefully integrate Zolvix into worm control strategies, before the other groups fail, will allow our sheep industry to reap the full benefits of this new novel group."
A study carried out by Novartis in conjunction with the Hopkirk Research Institute showed that Zolvix treated sheep gained 33.5%, or 2.8 kg deadweight, more than sheep treated with a drench to which they were resistant.
Novartis Animal Health Brand Manager Simon Harris said: "Parasite resistance is a growing problem that decreases the productivity of sheep of all ages. Many veterinarians and farmers are concerned about this, with an increasing number of farmers reporting resistance to the three groups of wormers that have been available up to now, so the introduction of Zolvix is very timely."
At the same time, the company has also launched an award-winning new drenching system designed to offer 'a superior drenching experience for both animal and operator'. The new Optiline Drencher and Optivix backpack system were developed in collaboration with drenching specialists Simcro Tech Ltd.
The Optiline Drencher has already won several design and engineering awards, including a bronze award in the 2009 NZ BEST design awards, a coveted International Forum (IF) 2010 product design award from Germany and the prestigious Bayer Innovators Award for design and engineering.
It was also a finalist in the New Zealand Agritech Innovation Awards reached the finals in three categories of the 2009 New Zealand Trade and Enterprise International Business Awards.
The Optiline drencher is coupled with a durable, light Optivix backpack that has been specially tailored to provide left or right-handed operators with the same wide range of adjustment. It also has two drench cradles - at chest and hip level - to ensure maximum comfort.
Mr Harris said: "This drencher is best appreciated during use. Contact your local Novartis Animal health representative to arrange a trial."
Eurovet Animal Health Ltd has entered the UK veterinary pharmaceuticals market with a portfolio of products including a levothyroxine tablet for the treatment of canine hypothyroidism, injectables for cattle and pigs, a xylazine injection for use in cattle, horses, dogs & cats and a corticosteroid for use in horses, cattle, pigs, cats and dogs.
Eurovet Animal Health is a subsidiary of Dutch company, AUV, which was established in 1969 as a cooperative by 100 veterinary surgeons, and is now jointly owned by 2000 vets. The company says this gives it a unique perspective on the products that veterinary surgeons really need and want. And whilst Eurovet Animal Health is still relatively small in the UK, the parent company Eurovet Animal Health BV owns state-of-the-art manufacturing facilities and provides access to international expertise, support and resources.
Eurovet Animal Health Ltd will be offering Eurovet products previously distributed by partner companies in the UK, so vets can expect to see brands they know and trust, as well as new brands. Existing products will be available from veterinary wholesalers and include:
Further information about Eurovet's range of products is available from Eurovet Animal Health, Compass House, Chivers Way, Histon, Cambridge, CB24 9AD Tel: 01223 257933 E-mail office@eurovet-ah.co.uk http://www.eurovet-ah.co.uk/
Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
JSAP is pleased to announce that it will provide two seminars to be held during BSAVA Congress, in conjunction with the Clinical Research Abstract sessions, aimed at providing guidance for those seeking to publish their research and wishing to critically evaluate published studies. These sessions are free to attend but numbers are limited (see below).
Friday 9 April
12.05–12.35 (Hall 7b, ICC)
How To Put A Paper Together
Speaker: Malcolm Ness
BVetMed CertSAO DipECVS FRCVS
Vets in practice are ideally placed to conduct and publish clinical research because they are the ones actually seeing the cases! Many practitioners are put off because of a perceived difficulty in "getting published". This is largely fear of the unknown and like most things, once you know the rules, it is easier to play the game. The purpose of the seminar is to look at and learn the "rules" of writing a paper for publication in a peer reviewed veterinary journal. Areas considered will include:
What makes a good clinical research project?
Understanding the standard format for writing a paper – which bits go where, and why
The peer review process – how it works and why
Handling rejection!
The seminar is intended for anyone aspiring to seeing their work published in a peer reviewed veterinary journal including interns, residents, researchers and referral clinicians but especially colleagues working in primary care clinical practice.
Saturday 10 April
12.05–12.35 (Hall 7a, ICC)
Critical Reading
Speaker: Adrian Boswood
MA VetMB DVC DipECVIM-CA FHEA MRCVS
Reading original articles from the peer-reviewed literature can at first seem a daunting task. It is however, only by evaluating full papers (rather than skimming and believing abstracts!) that the strengths and weaknesses of published studies can be truly appreciated. This seminar at BSAVA congress is designed to give attendees a basic understanding of how to approach original papers.
The seminar will begin with an outline of the formal structure of a scientific paper and give guidelines for readers as to where critical information in the paper should be sought. Examples from the veterinary and medical literature examples of good (and in some cases bad!) practice will be used to illustrate this critical approach. The seminar is designed for practitioners wishing to develop a more questioning approach and for those in the early stages of a clinical academic career (although anyone is welcome to attend).
Adrian Boswood is Professor of Veterinary Cardiology at the Royal Veterinary College and a RCVS Recognised Specialist in Veterinary Cardiology and a European Specialist in Veterinary Internal Medicine (Cardiology).
Malcolm Ness is Founding Partner at Croft Veterinary Hospital and a RCVS and European Recognised Specialist in Small Animal Surgery.
Spaces for these seminars are limited, and those attending the Saturday seminar will be sent a paper to evaluate in advance that will be discussed at the meeting. Therefore, if you would like to attend either of these seminars please contact Ian Mellor, Media Sales Manager, British Small Animal Veterinary Association (email: i.mellor@bsava.com) by Friday 26 March.
The RCVS is to embark on a communications campaign over the next few months to raise awareness amongst the general public of the difficulties that vets face in providing out-of-hours emergency cover, and the responsibilities incumbent on animal owners to know what to do in a veterinary emergency.
Emergency cover has been high on the College's agenda for some time.
Over the last 18 months, the RCVS 24/7 Working Party has considered the ongoing desire of vets to continue to offer emergency care 24 hours a day, and the feasibility of delivering this, against a backdrop of the Working Time Regulations, geographical variations in animal and vet density, and increasing practice diversity.
Working Party meetings have been supported by a survey of how vets are currently meeting their 24/7 requirements, a seminar of stakeholders and regular informal polls at RCVS Question Time meetings.
It was agreed at the September 2009 meeting of Advisory Committee, to which the Working Party reports, that the majority of vets remain willing to deliver emergency cover 24/7. Advisory Committee recommended that a communications project be undertaken to help raise awareness amongst the general public and animal owners that although the veterinary profession continues to make this voluntary commitment, EU rules, geography and financial constraints impose some limitations.
This campaign will kick off soon and focus on spreading messages via animal-owner publications and websites. The responsibility of pet owners to know how they can access emergency care for their animal in advance of need will be stressed, as will the fact that in the absence of an NHS for pets, emergency care is a service for which practices must charge a realistic fee (which is likely to be higher than for day-time work).
The campaign will also outline vets' responsibilities as part of the Guide, so the public knows what it can reasonably expect. It would be helpful if practices could ensure they have clear information available on their 24/7 arrangements - as outlined in the Guide - should this campaign stimulate requests from clients.
Jerry Davies, who chaired the Working Party, said: "There is overwhelming opinion within the profession that we must continue to provide round-the-clock veterinary care. The main tenet of the Working Time Regulations is that workers should not have their health or, importantly, skills compromised by unreasonable working patterns. Vets, VNs and the animals they care for deserve the same level of protection.
"However, this legislation has made continuing to provide such care at a reasonable cost to the animal owner a significant challenge. Meeting this challenge will require the understanding and cooperation of the animal owning public.
"If clients can be flexible and accept slightly longer response times, an effective service can still be sustained. The key is for all animal owners to establish, in advance, exactly what will be involved should they need to access veterinary care in an emergency. This simple step will help optimise response times and eliminate the frustration, confusion and inevitable dissatisfaction that may arise if ill-prepared."
Following a five-year review of the Practice Standards Scheme, new standards will take effect from 1 April 2010, and be formally launched at the British Small Animal Veterinary Association Congress in Birmingham (8-11 April).
The Scheme, to which around 50% of practice premises are now signed up, exists to raise standards for the benefit of the public, as well as employees. The review was undertaken by the Practice Standards Group, which includes representatives from all of the key veterinary and veterinary nursing organisations. Its objective was to ensure that standards remain relevant and achievable, while representing better practice. The Group took on board improvements in practice over the last five years, and feedback from inspectors and practices.
Practice Standards Group Chairman, Jill Nute said: "It was important that the Group took account of what the public might reasonably expect of a well-equipped, professional practice. We have made some adjustments to the original standards, placing greater emphasis on clinical outcomes and training."
She added: "To ensure the Scheme goes beyond a 'box-ticking exercise', the emphasis for inspectors has moved towards assessing how standards are applied. For example, not just noting whether a protocol exists for the servicing of anaesthetic equipment, but asking staff involved how this is carried out and what checks are made on a daily basis to ensure the equipment is satisfactory."
The numbered 'tiers' have gone, as these were shown to be confusing. The descriptive categories (Core, GP, Hospital), together with differentiations (equine, small animal, farm animal, emergency services clinic), remain. In addition, to encourage more farm animal practices into the Scheme at GP level, 'where applicable' has been added to certain GP standards, so that those without small animal or equine facilities can comply.
There are some new standards - such as the requirement for annual appraisal systems for all clinical staff. In other cases, as expectations of better practice increase, standards that were previously for Hospitals must now be met by General Practices, and some of those for GPs now apply across the board.
Another change has been in the Manual (see www.rcvs.org.uk/newPSSmanual), which now incorporates guidance alongside the standards rather than in a separate document. The new format clarifies the derivation of each standard, so that legislative requirements are distinguished from those required under the RCVS Guide to Professional Conduct and those indicated by better practice.
Practices already on the Scheme will be given plenty of time to comply.
Visit stand 911 at BSAVA Congress for more information, or attend Hall 6 at 3.30pm on Saturday 10 April for a presentation on the changes.